Judith M. Matthews
2018
In 2018, Judith M. Matthews earned a total compensation of $611.7K as Chief Financial Officer at Iterum Therapeutics plc, a 92% increase compared to previous year.
Compensation breakdown
| Non-Equity Incentive Plan | $126,175 |
|---|---|
| Option Awards | $178,786 |
| Salary | $305,707 |
| Other | $995 |
| Total | $611,663 |
Matthews received $305.7K in salary, accounting for 50% of the total pay in 2018.
Matthews also received $126.2K in non-equity incentive plan, $178.8K in option awards and $995 in other compensation.
Rankings
In 2018, Judith M. Matthews' compensation ranked 11,210th out of 14,244 executives tracked by ExecPay. In other words, Matthews earned more than 21.3% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 11,210 out of 14,244 | 21st |
Division Manufacturing | 4,535 out of 5,765 | 21st |
Major group Chemicals And Allied Products | 1,718 out of 2,128 | 19th |
Industry group Drugs | 1,458 out of 1,817 | 20th |
Industry Pharmaceutical Preparations | 1,119 out of 1,391 | 20th |
Source: SEC filing on April 25, 2019.
Matthews' colleagues
We found two more compensation records of executives who worked with Judith M. Matthews at Iterum Therapeutics plc in 2018.